BioCentury
ARTICLE | Distillery Therapeutics

RNF41 gene therapy for chronic liver disease

August 10, 2023 1:03 AM UTC

Increasing the expression of macrophage RNF41 — an E3 ubiquitin protein ligase that drives degradation of various proinflammatory cytokine receptors, adapter molecules, and kinases — could help treat chronic liver disease by stimulating liver regeneration, and alleviating inflammation, injury, and fibrosis.

In macrophages isolated from human and mouse liver specimens, RNF41 expression was lower in patients with liver cirrhosis and mice with liver fibrosis than healthy individuals and mice, respectively. ...

BCIQ Company Profiles

University of Barcelona